CNR Institutional Research Information System

CAMORANI, SIMONA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 59
AS - Asia 57
EU - Europa 11
Totale 127
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 59
SG - Singapore 47
KR - Corea 10
IT - Italia 8
FI - Finlandia 2
SK - Slovacchia (Repubblica Slovacca) 1
Totale 127
Salva come PNG Salva come JPEG
Città #
Santa Clara 46
Singapore 33
Seoul 10
Aversa 2
Helsinki 2
Naples 2
Modena 1
Nitra 1
Totale 97
Salva come PNG Salva come JPEG
Nome #
Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies 12
Novel Aptamers Selected on Living Cells for Specific Recognition of Triple-Negative Breast Cancer 11
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer 11
Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors 9
Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells 8
Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles 8
Optimization of Short RNA Aptamers for TNBC Cell Targeting 8
Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells 7
Aptamer-Based Strategies to Boost Immunotherapy in TNBC 7
Aptamer-mediated impairment of EGFR-integrin alpha v beta 3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers 6
Novel human bispecific aptamer-antibody conjugates for efficient cancer cell killing 6
Synthesis and functionalization of casein nanoparticles with aptamers for triple-negative breast cancer targeting 6
null 6
TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities 6
Dual Oncogenic/Anti-Oncogenic Role of PATZ1 in FRTL5 Rat Thyroid Cells Transformed by the Ha-Ras(V12) Oncogene 5
PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype 5
inhibition of bone marrow-derived mesenchymal stem cells homing towards triple-negative breast cancer microenvironment using an anti-PDGFRbeta aptamer 5
Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells. 5
Aptamers and antibodies: rivals or allies in cancer targeted therapy? 5
Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFR? Aptamer. Theranostics. 4
Trabectedin modulates the senescence-associated secretory phenotype and promotes cell death in senescent tumor cells by targeting NF-?B 4
Profiling cancer cells by cell-selex: Use of aptamers for discovery of actionable biomarkers and therapeutic applications thereof 4
Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood-Brain Barrier. 4
Highlighting the potential of aptamer-based strategy to treat EGFRvIII-positive glioblastoma. Cancer Cell Microenviron. 4
Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRbeta aptamer 4
Coupling aptamers to short interfering RNAs as therapeutics 3
Ipilimumab and its derived EGFR aptamer-based conjugate induce efficient NK cell activation against cancer cells 3
null 2
Oligonucleotide aptamers for glioma targeting: an update. 2
Totale 170
Salva come PNG Salva come JPEG
Categoria #
all - tutte 719
article - articoli 719
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.438
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202440 0 0 0 0 0 0 0 0 4 0 10 26
2024/2025130 18 7 48 12 45 0 0 0 0 0 0 0
Totale 170